EUVIMEDEUVIMED entdecken
Crossref

Over‐expression of N‐acetylaspartate synthase exacerbates pathological energetic deficit and accelerates cognitive decline in the 5xFAD mouse

Jeremy S Francis iD, Quy Nguyen, Vladimir Markov, Paola Leone

Journal of Neurochemistry · 2024-02 · 168 (2) · 69-82

DOI: 10.1111/jnc.16044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurochemistry, online erschienen am 05.01.2024. Verfasst von Jeremy S Francis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cell & Gene Therapy Center, Department of Cell Biology and Neuroscience, Rowan University School of Osteopathic Medicine, Stratford, New Jersey, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N‐acetylaspartate (NAA) is an abundant central nervous system amino acid derivative that is tightly coupled to mitochondria and energy metabolism in neurons. A reduced NAA signature is a prominent early pathological biomarker in multiple neurodegenerative diseases and becomes progressively more pronounced as disease advances. Because NAA synthesis requires aspartate drawn directly from mitochondria, we argued that this process is in direct competition with oxidative phosphorylation for substrate and that sustained high levels of NAA synthesis would be incompatible with pathological energy crisis. We show here that over‐expression of the rate‐limiting NAA synthetic enzyme in the hippocampus of the 5x familial Alzheimer's disease (5xFAD) mouse results in an exaggerated pathological ATP deficit and accelerated cognitive decline. Over‐expression of NAA synthase did not increase amyloid burden or result in cell loss but did significantly deplete mitochondrial aspartate and impair the ability of mitochondria to oxidize glutamate for adenosine triphosphate (ATP) synthesis. These results define NAA as a sink for energetic substrate and suggest initial pathological reductions in NAA are part of a response to energetic crisis designed to preserve substrate bioavailability for mitochondrial ATP synthesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCognitive DysfunctionMiceAnimalsAspartic AcidAdenosine Triphosphate

Stichwörter der Autor:innen

N-acetylaspartateNeurodegenerative diseasemetabolic decline

Substanzen

N-acetylaspartateAspartic AcidAdenosine Triphosphate

Autor:innen und Institutionen

  • Cell & Gene Therapy Center, Department of Cell Biology and Neuroscience, Rowan University School of Osteopathic Medicine, Stratford, New Jersey, USA.

ORCID-Profile: Jeremy S Francis

Zitieren

APA

Francis, J. S., Nguyen, Q., Markov, V., & Leone, P. (2024). Over‐expression of N‐acetylaspartate synthase exacerbates pathological energetic deficit and accelerates cognitive decline in the 5xFAD mouse. Journal of Neurochemistry, 168(2), 69-82. https://doi.org/10.1111/jnc.16044

Vancouver

Francis JS, Nguyen Q, Markov V, Leone P. Over‐expression of N‐acetylaspartate synthase exacerbates pathological energetic deficit and accelerates cognitive decline in the 5xFAD mouse. Journal of Neurochemistry. 2024;168(2):69-82. doi:10.1111/jnc.16044

BibTeX
@article{Francis2024,
  author = {Francis, Jeremy S and Nguyen, Quy and Markov, Vladimir and Leone, Paola},
  title = {Over‐expression of N‐acetylaspartate synthase exacerbates pathological energetic deficit and accelerates cognitive decline in the 5xFAD mouse},
  journal = {Journal of Neurochemistry},
  year = {2024},
  volume = {168},
  number = {2},
  pages = {69--82},
  doi = {10.1111/jnc.16044}
}
Kostenlos starten →